Proceeds will fuel BRIJ Medical's continued commercial expansion of BRIJ-SEAL™ and the upcoming launch of BRIJ-Ag™, building on strong investor confidence and growing market momentum.

所得资金将推动 BRIJ Medical 持续扩大 BRIJ-SEAL™ 的商业化规模，并推进即将上市的 BRIJ-Ag™，此举建立在投资者信心强劲和市场势头不断增长的基础之上。

SAN DIEGO

圣迭戈

,

，

Nov. 3, 2026

2026年11月3日

/PRNewswire/ -- BRIJ Medical, a medical technology company advancing surgical incision management, today announced that it has closed a $5M financing round. The round was led by the company's Board of Directors, with most of the participation from existing investors.

/美通社/ -- 致力于推进手术切口管理的医疗科技公司BRIJ Medical今日宣布完成一轮500万美元的融资。本轮融资由公司董事会领投，现有投资者为主要参与方。

The company initially set out to raise $3M and increased the round to $5M in response to investor demand.

该公司最初计划融资300万美元，后因应投资者需求将本轮融资额提高至500万美元。

BRIJ's product portfolio is now being used by surgeons across orthopedic, plastic and spine surgery, spanning a broad range of surgical procedures. Following the July 2026 launch of BRIJ-SEAL™, the company's advanced wound closure device, BRIJ is building commercial momentum and preparing to introduce BRIJ-Ag™, its silver-based antimicrobial wound dressing, later this quarter..

BRIJ的产品组合正被骨科、整形外科和脊柱外科领域的广大外科医生所使用，涵盖多种外科手术。继2026年7月推出其先进的伤口闭合装置BRIJ-SEAL™之后，BRIJ正在积累商业势头，并准备在本季度晚些时候推出基于银的抗菌伤口敷料BRIJ-Ag™。

'We set out to raise $3 million and chose to upsize the round because our investors saw the same opportunity we do,' said

“我们原计划筹集300万美元，并决定扩大本轮融资规模，因为我们的投资者看到了与我们相同的机遇，”

Tim Gleeson

蒂姆·格里森

, CEO of BRIJ Medical. 'This investment allows us to put BRIJ-SEAL and Brijjit® in front of more surgeons while accelerating the launch of BRIJ-Ag. We're seeing growing interest across multiple surgical specialties, and we're focused on building the commercial reach and infrastructure to meet that demand.'.

BRIJ Medical 首席执行官表示：“这笔投资使我们能够向更多外科医生展示 BRIJ-SEAL 和 Brijjit®，同时加速 BRIJ-Ag 的上市。我们注意到多个外科专业领域的兴趣日益增长，因此我们正专注于构建商业覆盖范围和基础设施，以满足这一需求。”

John Grotting

约翰·格罗廷

, Chairman of the Board, added: 'We increased our commitment because we believe BRIJ is at an important inflection point. The company has developed a differentiated portfolio addressing meaningful needs in surgical care, and we're pleased to support the team as it enters its next phase of growth.'

董事会主席补充道：“我们加大了承诺力度，因为我们相信BRIJ正处于一个重要的转折点。该公司已开发出差异化的产品组合，以满足外科护理领域的重大需求，我们很高兴在该团队进入下一增长阶段之际为其提供支持。”

Funding to Accelerate Commercial Growth

加速商业增长的融资

Proceeds from the round will primarily support BRIJ Medical's commercial expansion and upcoming product launch initiatives. With an expanding product portfolio, growing surgeon engagement and increased investment in its commercial organization, BRIJ Medical is positioned to build on its momentum and advance its mission to redefine surgical closure and incision management..

本轮融资所得将主要用于支持 BRIJ Medical 的商业扩张及即将推出的产品发布计划。凭借不断扩大的产品组合、日益增长的 Surgeon 参与度以及对其商业组织增加的投入，BRIJ Medical 有望延续其发展势头，进一步推进其重新定义手术闭合与切口管理的使命。

About BRIJ Medical

关于 BRIJ Medical

BRIJ Medical

BRIJ医疗

is redefining incision management through active tension offloading and advanced incision protection. With a portfolio of innovative solutions that cover, protect, and reinforce incisions, BRIJ empowers surgeons from closure through recovery.

BRIJ 通过主动张力卸载和先进的切口保护技术，重新定义切口管理。凭借涵盖、保护及强化切口的创新解决方案组合，BRIJ 为外科医生提供从缝合闭合到术后康复的全程支持。

BRIJ-SEAL is an advanced wound closure device that provides a 14-day bacterial barrier, while Brijjit® is an active tension offloading device clinically shown to eliminate up to 100% of incisional tension.

BRIJ-SEAL 是一种先进的伤口闭合装置，可提供为期14天的细菌屏障；而 Brijjit® 是一种主动张力卸载装置，经临床验证可消除高达100%的切口张力。

Trusted by plastic and orthopedic surgeons across the U.S. and Canada, BRIJ Medical brings greater control and confidence to incision management.

BRIJ Medical 深受美国和加拿大整形外科与骨科医生的信赖，为切口管理带来更高的可控性与信心。

Learn more at

了解更多，请访问

www.BRIJmedical.com

www.BRIJmedical.com

.

。

*Clinical data available at Brij Medical's website:

*Brij Medical 网站提供的临床数据：

Clinical Evidence – BRIJ Medical

临床证据 – BRIJ Medical

SOURCE BRIJ Medical

来源：BRIJ Medical